scutellarin has been researched along with Cardiac Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aini, M; Cai, R; Gao, Z; Huo, Y; Mijiti, A; Qie, R; Wang, Z | 1 |
1 other study(ies) available for scutellarin and Cardiac Diseases
Article | Year |
---|---|
Scutellarin alleviates type 2 diabetes (HFD/low dose STZ)-induced cardiac injury through modulation of oxidative stress, inflammation, apoptosis and fibrosis in mice.
Topics: Animals; Apigenin; Apoptosis; Biomarkers; Blood Glucose; Body Weight; Cardiovascular Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucuronates; Heart Diseases; Inflammation; Lipids; Male; Mice; Oxidative Stress; RNA, Messenger | 2021 |